However, treatment of SW1990 cells of pancreatic cancer with 1,3,4-O-Bu3ManNAc, which increases the sialylation of one N-glycan site on EGFR, increases the rate of EGFR internalization and degradation [96]. The gene discussed is EGFR; the disease is pancreatic neoplasm.